Metacrine is a clinical-stage biopharmaceutical company that specializes in developing innovative drugs to treat liver and gastrointestinal diseases. Their main focus is on the farnesoid X receptor (FXR) program, which targets multiple liver and GI diseases. In addition to the FXR program, Metacrine also explores other drug targets through their internal drug discovery and development capabilities...